Search

Displaying results 7281 - 7290 of 8010 in total
  1. Drug

    Lexacalcitol

    go.drugbank.com/drugs/DB03451
    Experimental

    These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. It is known to target the vitamin D3 receptor.

  2. Drug

    Phenamazoline

    go.drugbank.com/drugs/DB19509
    Experimental

    The usage of the INN stem '-azoline' in the name indicates that Phenamazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  3. Drug

    Tinazoline

    go.drugbank.com/drugs/DB20310
    Experimental

    The usage of the INN stem '-azoline' in the name indicates that Tinazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  4. Drug

    Nemazoline

    go.drugbank.com/drugs/DB21115
    Experimental

    The usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  5. Drug

    Alphameprodine

    go.drugbank.com/drugs/DB01499
    ExperimentalIllicit

    Alphameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances.

  6. Drug

    Betameprodine

    go.drugbank.com/drugs/DB01552
    ExperimentalIllicit

    Betameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances.

  7. Drug

    Urelumab

    go.drugbank.com/drugs/DB12077
    Investigational

    The antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with

  8. Drug

    Ontuxizumab

    go.drugbank.com/drugs/DB16270
    Investigational

    Ontuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1).

  9. Drug

    Elzasonan

    go.drugbank.com/drugs/DB18969
    Investigational

    Elzasonan is under investigation in clinical trial NCT00275197 (A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive

  10. Drug

    Mevidalen

    go.drugbank.com/drugs/DB19034
    Investigational

    Mevidalen is under investigation in clinical trial NCT03305809 (A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or